瑞生源riseng品牌怎么样 申请店铺

我要投票 瑞生源riseng在果酒行业中的票数:54 更新时间:2025-01-12
瑞生源riseng是哪个国家的品牌?「瑞生源riseng」是 湖南瑞生源生物科技有限公司 旗下著名品牌。该品牌发源于湖南省娄底市,由创始人曾长青在2009-02-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
瑞生源riseng怎么样

公司旨在传承瑞生老人情怀,生产高品质健康杨梅养生产品,笃行诚信经营理念、弘扬坦诚高雅杨梅文化,以激励瑞生源人勇于承担社会责任的开拓精神!

杨梅,漫山遍野,却未能改变家乡贫穷落后的困境。

感恩乡情,三位农民的儿子,肩负起解决杨梅销售困难、发展杨梅产业的使命,托起农民致富的希望。

2008年5月,在微生物学家、湖南农业大学周传云教授的技术支持下,开始杨梅深加工项目的实验,生物发酵杨梅果酒的技术应用成功。

2008年12月,86位农民在三人赤情感召之下,在具备地理环境、适宜的气候条件和良好的空气质量,拥有1000余年历史的“杨梅故里”——湖南冷水江铁山冲,共同投资成立了湖南瑞生源生物科技有限公司,注册资金868万元。

2009年2月,按果酒生产要求高标准开工建设瑞生源生态杨梅产业园,仅用86天时间,安全地达成当年如期收购杨梅的目标,带来了别有一番天地的盎然生机。

2012年,在各级部门和领导的关心支持下,获得中国供销合作社新网工程项目扶持资金250万,得到政策扶持资金累计400多万。

2010年6月,被授予“湖南省娄底市农业产业化龙头企业”称号;2013年1月,被授予“湖南省林业产业化龙头企业”称号,并荣获国家、省、市各种荣誉称号30多项。

历时5年,改造荒山开发杨梅基地1000余亩,并服务于湖南娄底29个杨梅基地,有力地促进娄底30万亩杨梅产业经济带的形成和发展。公司累积投资3856万,收购杨梅1600余吨,为农民创造收益672.66万元,酿造杨梅果酒800多吨,生产出杨梅干红、杨梅冰酒等6款系列产品,生产规模达到年均加工杨梅鲜果2000吨,产值达到5000万。

一路走来有酸有甜,油然而生的责任感,加盟的员工始终不弃不离、忠于公司、忠于使命,公司股东依然充满希望和信心,父老乡亲对公司充分理解、满怀期待。历经的坎坷成就了瑞生源坚韧不拔的意志,凝聚了瑞生源不断进取的力量。

瑞生源生态杨梅产业园预算投资3.8亿,规划建成年加工50000吨杨梅鲜果生产基地和技术研发中心、20000亩生态杨梅示范基地、陈酿酒窖、杨梅文化传播中心、杨梅文化博览园、山水风光旅游区等项目。

依托本地特色资源,打造集杨梅深加工和技术研发、商务会所、休闲旅游和杨梅文化传播于一体的示范产业园。届时将为农民每年创造直接收益1.2亿元,受益农户15000余户,户均每年增收8000元,公司年产值达9亿元,创造利润3亿元,税收1.2亿元,直接提供500余个就业岗位,带动社会5000余人就业,并有效推动第三产业健康发展!


The company aims to inherit the feelings of old people of Ruisheng, produce high-quality healthy bayberry health care products, adhere to the honest management concept, carry forward the honest and elegant bayberry culture, and encourage the pioneering spirit of ruishengyuan people to bear social responsibility bravely! Bayberry, everywhere, has failed to change the plight of poverty and backwardness in their hometown. Thanks to the local conditions, the sons of the three farmers shoulder the mission of solving the sales difficulties of Bayberry and developing the industry of bayberry, and hold up the hope of the farmers to become rich. In May 2008, with the technical support of microbiologist and Professor Zhou Chuanyun of Hunan Agricultural University, the experiment of Bayberry deep processing project was started, and the technology of biological fermentation of bayberry wine was successfully applied. In December 2008, 86 farmers, inspired by the passion of the three, jointly invested and established Hunan ruishengyuan Biotechnology Co., Ltd., with a registered capital of 8.68 million yuan, in tieshanchong, Lengshuijiang, Hunan Province, the hometown of bayberry, which has a history of more than 1000 years and possesses geographical environment, suitable climatic conditions and good air quality. In February 2009, the construction of ruishengyuan ecological arbutus Industrial Park was started according to the high standard of fruit wine production. It took only 86 days to achieve the goal of purchasing arbutus as scheduled in that year, bringing about a lot of vitality. In 2012, with the care and support of departments and leaders at all levels, it obtained 2.5 million yuan of support funds for the new network project of China supply and marketing cooperatives, and more than 4 million yuan of policy support funds. In June 2010, it was awarded the title of "leading enterprise of agricultural industrialization in Loudi City, Hunan Province"; in January 2013, it was awarded the title of "leading enterprise of forestry industrialization in Hunan Province", and won more than 30 national, provincial and municipal honorary titles. It took five years to transform the barren mountain to develop more than 1000 mu of Bayberry base and serve 29 bayberry bases in Loudi, Hunan Province, effectively promoting the formation and development of 300000 mu of Bayberry industrial economic belt in Loudi. The company has accumulated investment of 38.56 million yuan, purchased more than 1600 tons of bayberry, created revenue of 6.7266 million yuan for farmers, brewed more than 800 tons of bayberry wine, and produced 6 series products such as red bayberry and ice wine, with an annual production scale of 2000 tons of processing fresh bayberry fruit and an output value of 50 million yuan. Along the way, there is a sense of responsibility that comes naturally. The employees who join in the company are always loyal to the company and the mission. The shareholders of the company are still full of hope and confidence, and their parents and villagers fully understand and look forward to the company. Through the ups and downs, ruishengyuan's indomitable will has been achieved, and the strength of ruishengyuan's continuous progress has been condensed. Ruishengyuan ecological arbutus Industrial Park has a budget investment of 380 million yuan, and plans to build a production base and technology research and Development Center for processing 50000 tons of arbutus fruit, a 20000 mu ecological arbutus demonstration base, a wine cellar for aging, a arbutus Culture Communication Center, a arbutus Culture Expo Park, a landscape tourism area and other projects. Relying on the local characteristic resources, we will build a demonstration industrial park integrating the deep processing and technology research and development of bayberry, business club, leisure tourism and the spread of Bayberry culture. At that time, it will create 120 million yuan of direct income for farmers every year, more than 15000 beneficiary farmers, 8000 yuan of annual income per household, 900 million yuan of annual output value of the company, 300 million yuan of profits, 120 million yuan of tax revenue, more than 500 jobs directly provided, more than 5000 people in the society will be employed, and the healthy development of the tertiary industry will be effectively promoted!

本文链接: https://brand.waitui.com/c82bb4e94.html 联系电话:07385763999

千城特选小程序码

7×24h 快讯

振华股份:公司总经理柯愈胜因短线交易被证监会立案

振华股份公告,公司总经理柯愈胜于2025年1月10日收到《中国证券监督管理委员会立案告知书》,因其涉嫌短线交易振华股份股票,根据相关法律法规,证监会决定对其立案。本次事项系对柯愈胜个人的调查,不会对公司董事会运作及公司日常经营活动产生重大影响。(财联社)

2小时前

*ST花王:撤销退市风险警示并继续实施其他风险警示

*ST花王公告,因公司重整而触及的退市风险警示情形已经消除,上海证券交易所同意撤销对公司股票实施的退市风险警示并继续实施其他风险警示。公司股票将于2025年1月13日开市起停牌1天,并于2025年1月14日开市起复牌。复牌后,公司A股简称将变更为“ST花王”,股票代码仍为603007,股票价格的日涨跌幅限制仍为5%。(财联社)

2小时前

6连板粤宏远A:可能存在短期涨幅较大后下跌的风险

粤宏远A发布异动公告,公司股票价格短期涨幅显著高于深证A指,存在市场情绪过热的情形,可能存在短期涨幅较大后下跌的风险。近期公司经营情况未发生重大变化,也不存在应披露而未披露的重大信息,敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。(财联社)

2小时前

恒瑞医药:注射用瑞卡西单抗获得药品注册证书

恒瑞医药(600276)1月12日晚间公告,公司子公司广东恒瑞医药有限公司收到国家药监局核准签发注射用瑞卡西单抗的《药品注册证书》,该产品是公司在心血管疾病领域上市的首个1类创新药。(e公司)

2小时前

君实生物:氢溴酸氘瑞米德韦片用于治疗轻中度新型冠状病毒感染的成年患者的适应症获得国家药监局同意

君实生物公告,控股子公司上海旺实生物医药科技有限公司收到国家药监局核准签发的《药品补充申请批准通知书》,氢溴酸氘瑞米德韦片(商品名:民得维®,产品代号:VV116/JT001)用于治疗轻中度新型冠状病毒感染的成年患者的适应症获得国家药监局同意,由附条件批准转为常规批准。民得维®是一款口服核苷类抗病毒药物,可抑制SARS-CoV-2复制,对多种SARS-CoV-2突变株表现出显著的抗病毒作用。(财联社)

2小时前

本页详细列出关于笙夏的品牌信息,含品牌所属公司介绍,笙夏所处行业的品牌地位及优势。
咨询